PSIX: the cash flow

MyFinsight

For the year ending 2025-12-31, PSIX had -$13,543K decrease in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net income	113,987
Amortization of intangible assets	1,218
Depreciation	4,170
Noncash lease expense	6,063
Stock-based compensation expense	427
Amortization of financing fees	646
Deferred income taxes	-14,890
(credit) for losses in accounts receivable	-922
Increase in allowance for inventory obsolescence, net	118
Other adjustments, net	96
Accounts receivable	20,566
Inventories	33,426
Prepaid expenses	-1,896
Contract assets	-5,496
Other assets	7,205
Accounts payable	-10,084
Income taxes receivable	-5,457
Accrued expenses	-6,789
Other noncurrent liabilities	-10,665
Net cash provided by operating activities	24,113
Capital expenditures	9,973
Proceeds from disposal of assets	11
Net cash used in investing activities	-9,962
Repayment of long-term debt and lease liabilities	482
Proceeds from short-term financings	0
Repayment of short-term financings	25,000
Repurchases to settle tax withholding obligations for stock-based compensation awards	1,055
Payments of deferred financing costs	1,157
Net cash used in financing activities	-27,694
Net (decrease) increase in cash, cash equivalents, and restricted cash	-13,543
Cash, cash equivalents, and restricted cash at beginning of the year	58,491
Cash, cash equivalents, and restricted cash at end of the year	44,948

Unit: Thousand (K) dollars (except for numbers of shares and EPS).